TITLE

Tissue engineering (IBMS/JSBMR joint meeting 2013)

AUTHOR(S)
Tsumaki, Noriyuki
PUB. DATE
August 2013
SOURCE
IBMS BoneKEy;Aug2013, Vol. 10 Issue 8, p397
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Information about several papers discussed at the International Bone and Mineral Society and the Japanese Society for Bone and Mineral Research (IBMS/JSBMR) meeting held in Kobe Island, Japan on May 28-June 1, 2013 is presented. Topics include the induced pluripotent stem (iPS) cells for bone tissue engineering, the use of TiO2 scaffold for osteoblasts, and the signals that regulate bone regeneration. Shinya Yamanaka, Z. Xiangmei, and R. Baron were among who presented these papers.
ACCESSION #
100370834

 

Related Articles

  • On Novel Options for Oromaxillofacial Functional Restoration. Jiang, Xinquan // International Journal of Prosthodontics;2012, Vol. 25 Issue 2, p132 

    The article focuses on tissue engineering and regenerative medicine in oromaxillofacial functional restorations. It states that bone tissue engineering involves several key components, including growth factors, seeded cells, and three-dimensional biomaterial scaffolds. It mentions that bone...

  • Electrospun fibrous scaffold of hydroxyapatite/poly (ε-caprolactone) for bone regeneration. Li, Lingli; Li, Guang; Jiang, Jianming; Liu, Xiaona; Luo, Li; Nan, Kaihui // Journal of Materials Science: Materials in Medicine;Feb2012, Vol. 23 Issue 2, p547 

    Development of fibrous scaffold of hydroxyapatite/biopolymer nanocomposite offers great potential in the field of bone regeneration and tissue engineering. Hydroxyapatite (HA)/poly (ε-caprolactone) (PCL) fibrous scaffolds were successfully prepared by electrospinning dopes containing HA and...

  • Tissue Engineering Scaffolds Fabricated in Dissolvable 3D-Printed Molds for Patient-Specific Craniofacial Bone Regeneration. de la Lastra, Angela Alarcon; Hixon, Katherine R.; Aryan, Lavanya; Banks, Amanda N.; Lin, Alexander Y.; Hall, Andrew F.; Sell, Scott A. // Journal of Functional Biomaterials;Sep2018, Vol. 9 Issue 3, p46 

    The current gold standard treatment for oral clefts is autologous bone grafting. This treatment, however, presents another wound site for the patient, greater discomfort, and pediatric patients have less bone mass for bone grafting. A potential alternative treatment is the use of tissue...

  • Mini 'brains' built in lab for the first time.  // New Scientist;8/31/2013, Vol. 219 Issue 2932, p17 

    The article discusses research by Juergen Knoblich at the Institute of Molecular Biology (IMB) in Vienna, Austria, and colleagues in a 2013 issue of "Nature" magazine, reporting the use of induced pluripotent stem (iPS) cells to grow brain-like organs, called organoids.

  • Evaluation of 3D nano-macro porous bioactive glass scaffold for hard tissue engineering. Wang, S.; Falk, M. M.; Rashad, A.; Saad, M. M.; Marques, A. C.; Almeida, R. M.; Marei, M. K.; Jain, H. // Journal of Materials Science: Materials in Medicine;May2011, Vol. 22 Issue 5, p1195 

    Recently, nano-macro dual-porous, three-dimensional (3D) glass structures were developed for use as bioscaffolds for hard tissue regeneration, but there have been concerns regarding the interconnectivity and homogeneity of nanopores in the scaffolds, as well as the cytotoxicity of the...

  • Efficient derivation of osteoprogenitor cells from induced pluripotent stem cells for bone regeneration. Dogaki, Yoshihiro; Lee, Sang; Niikura, Takahiro; Iwakura, Takashi; Okumachi, Etsuko; Waki, Takahiro; Kakutani, Kenichiro; Nishida, Kotaro; Kuroda, Ryosuke; Kurosaka, Masahiro // International Orthopaedics;Sep2014, Vol. 38 Issue 9, p1779 

    Purpose: There has been great interest in the use of induced pluripotent stem cells (iPSCs) in bone regenerative strategies. To generate osteoprogenitor cells from iPSCs, the most widely used protocol relies on an intermediate using embryoid body (EB) formation. We hypothesized that an...

  • Cell Reprogramming, IPS Limitations, and Overcoming Strategies in Dental Bioengineering. Ibarretxe, Gaskon; Alvarez, Antonia; Cañavate, Maria-Luz; Hilario, Enrique; Aurrekoetxea, Maitane; Unda, Fernando // Stem Cells International;2012, p1 

    The procurement of induced pluripotent stem cells, or IPS cells, from adult differentiated animal cells has the potential to revolutionize future medicine, where reprogrammed IPS cells may be used to repair disease-affected tissues on demand. The potential of IPS cell technology is tremendous,...

  • Dedifferentiated adipocyte-derived progeny cells (DFAT cells): Potential stem cells of adipose tissue. Wei, Shengjuan; Zan, Linsen; Hausman, Gary J; Rasmussen, Theodore P; Bergen, Werner G; Dodson, Michael V // Adipocyte;Jul/Aug2013, Vol. 2 Issue 3, p1 

    Analyses of mature adipocytes have shown that they possess a reprogramming ability in vitro, which is associated with dedifferentiation. The subsequent dedifferentiated fat cells (DFAT cells) are multipotent and can differentiate into adipocytes and other cell types as well. Mature adipocytes...

  • Application of iPS Cells in Dental Bioengineering and Beyond. Liu, Pengfei; Zhang, Yanmei; Chen, Shubin; Cai, Jinglei; Pei, Duanqing // Stem Cell Reviews & Reports;Oct2014, Vol. 10 Issue 5, p663 

    The stem-cell-based tissue-engineering approaches are widely applied in establishing functional organs and tissues for regenerative medicine. Successful generation of induced pluripotent stem cells (iPS cells) and rapid progress of related technical platform provide great promise in the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics